PoliticalRepoPoliticalRepo

United Kingdom · Question · Written question

HL HL6113

Voluntary Scheme for Branded Medicines Pricing and Access: Life Sciences

answeredUnited Kingdom· UK Parliament· EN

Introduced

3 March 2023

Last action

Status

Answered

Sponsors

Subjects

Discovery layer

Source updated

20 March 2023

Summary

To ask His Majesty's Government, further to the Department of Health and Social Care’s ongoing Voluntary Price and Access Scheme (VPAS) pre-negotiation workshops, what assessment they have made of the (1) the impact of VPAS 2019 on the UK life science sec

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.